Showing 1 - 20 results of 36 for search 'William Jacot', query time: 0.05s
Refine Results
-
1
Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer by Florence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, Séverine Guiu, Séverine Guiu, Angélique Bobrie, Angélique Bobrie, William Jacot, William Jacot, William Jacot, William Jacot
Published 2022-12-01
Article -
2
-
3
-
4
-
5
Prognostic Value of CXCR2 in Breast Cancer by Florence Boissière-Michot, William Jacot, Julien Fraisse, Sophie Gourgou, Colin Timaxian, Gwendal Lazennec
Published 2020-07-01
Article -
6
-
7
Efficacy of a physiotherapy, yoga and patient education programme for patients with breast cancer and hormone therapy-induced pain: a multicentre randomised study protocol (SKYPE 2... by Marta Jarlier, William Jacot, Muriel Thomaso, Kerstin Faravel, Laetitia Meignant, Maguy Del Rio, Anne Stoebner
Published 2024-01-01
Article -
8
BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib by Carolina Velazquez, Esin Orhan, Imene Tabet, Lise Fenou, Béatrice Orsetti, José Adélaïde, Arnaud Guille, Simon Thézénas, Evelyne Crapez, Pierre-Emmanuel Colombo, Pierre-Emmanuel Colombo, Max Chaffanet, Daniel Birnbaum, Claude Sardet, William Jacot, William Jacot, Charles Theillet
Published 2023-03-01
Article -
9
-
10
Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer by Angélique Bobrie, Océane Massol, Jeanne Ramos, Caroline Mollevi, Evelyne Lopez-Crapez, Nathalie Bonnefoy, Florence Boissière-Michot, William Jacot
Published 2022-10-01
Article -
11
Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers by William Jacot, Aurélie Maran-Gonzalez, Océane Massol, Charlotte Sorbs, Caroline Mollevi, Séverine Guiu, Florence Boissière-Michot, Jeanne Ramos
Published 2021-12-01
Article -
12
-
13
-
14
-
15
A Phase II Multicenter Trial on High-Dose Vitamin D Supplementation for the Correction of Vitamin D Insufficiency in Patients with Breast Cancer Receiving Adjuvant Chemotherapy by Elodie Chartron, Nelly Firmin, Célia Touraine, Angélique Chapelle, Eric Legouffe, Lobna Rifai, Stéphane Pouderoux, Lise Roca, Véronique D’Hondt, William Jacot
Published 2021-12-01
Article -
16
Serum Matrix Metalloproteinase‐7 is an independent prognostic biomarker in advanced bladder cancer by Mounira El Demery, Gaiané Demirdjian‐Sarkissian, Simon Thezenas, William Jacot, Yassine Laghzali, Bruno Darbouret, Stéphane Culine, Xavier Rebillard, Pierre‐Jean Lamy
Published 2014-12-01
Article -
17
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study by Marie Viala, Akiko Chiba, Simon Thezenas, Laure Delmond, Pierre-Jean Lamy, Sarah L. Mott, Mary C. Schroeder, Alexandra Thomas, William Jacot
Published 2018-07-01
Article -
18
-
19
The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases by Amélie Darlix, Christophe Hirtz, Simon Thezenas, Aleksandra Maceski, Audrey Gabelle, Evelyne Lopez-Crapez, Hélène De Forges, Nelly Firmin, Séverine Guiu, William Jacot, Sylvain Lehmann
Published 2019-01-01
Article -
20
Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival by Hanane Mansouri, Lindsay B. Alcaraz, Caroline Mollevi, Aude Mallavialle, William Jacot, Florence Boissière-Michot, Joelle Simony-Lafontaine, Valérie Laurent-Matha, Pascal Roger, Emmanuelle Liaudet-Coopman, Séverine Guiu
Published 2020-05-01
Article